BASF Venture Capital is the corporate venture capital arm of BASF Group. They invest worldwide in promising young enterprises relevant to BASF’s current and future business fields and also in funds. Besides innovations in the fields of chemistry, new materials and sustainability, their areas of focus include digitization and new business models. They support their portfolio companies through selective interactions with the global research, partnership and customer networks of the BASF Group. They are headquartered in Ludwigshafen, Germany and have offices in San Francisco, Boston, Shanghai, Sao Paulo, and Tel Aviv.

BASF Venture Capital

ChooseMaryland is the web site for the Maryland Department of Business and Economic Development. Here you will find information about Maryland's outstanding business climate, as well as programs available to both small and large companies to ensure their success. It also includes information on financing, workforce training, exporting, trade and small and minority business assistance.  The department's mission is simple: to attract new businesses, stimulate private investment and create jobs, encourage the expansion and retention of existing companies and provide businesses in Maryland with workforce training and financial assistance. The department promotes the state's many economic advantages and markets local products and services at home and abroad to spur development, international trade and tourism. Because they are a major economic generator for the state, the department also supports the arts, film production, sports and other special events.  The department continues to build on the state's prosperity by promoting its positive business climate and outstanding quality of life. In addition, DBED will ensure that all areas of the state share equally in its prosperity and will continue to promote Maryland as a leader in the New Economy.

Maryland Department of Business and Economic Development

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Arancia International

Sherbrooke Capital invests in the health and wellness industry and is a Massachusetts-based venture capital firm.

Sherbrooke Capital

SAM Private Equity is an investment firm specialized in direct and fund of funds investments. Within fund of funds, it invests in venture capital funds, private equity funds, secondary investment funds, primary and secondary cleantech funds, and mid- and large-sized buyout funds. Within direct investments, it focuses on growth capital, development capital, later stage, late venture, early venture, buyout, and middle market investments.   The firm seeks to invest in the energy, energy generation, energy storage, energy infrastructure, health and nutrition, social and governance practices, resource productivity, energy efficiency, transportation, water and wastewater, air and environment, materials, manufacturing and industrial, agriculture, and recycling and waste sectors.   Within energy generation, the firm invests in wind, solar, hydro, marine, biofuels, geothermal, clean coal technologies, and coal bed methane. In energy storage, the company’s the focus is on fuel cells, advanced batteries, and hybrid systems. Within energy infrastructure, it invests in management, smart grids, and transmission. In energy efficiency, the firm focuses on lighting, buildings, glass, ESCOs, combined heat, and power. Within transportation, it invests in structures, fuels, hydrogen highways, biofuel distribution, electric vehicles, and vehicle sharing. In water and wastewater, the firm invests in water treatment, water conservation, wastewater treatment, and desalination. Within air and environment, it focuses on cleanup and safety, emissions control, monitoring and compliance, carbon capture, and SOX and NOX removal.   In materials, the firm invests in nanotechnology, bio, and chemical fields. Within manufacturing, it invests in advanced packaging, monitoring and control, smart production, as well as in energy efficiency, power production from waste and biomass, material recycling and biological materials, water technologies, and air treatment technologies. In agriculture, the firm invests in natural pesticides, land management, and aquaculture. Within recycling and waste, it invests in recycling and waste treatment.   SAM Private Equity also invests in electric power transmission and control, technology hardware and equipment, biotechnology, food products, sanitary services, recycling and reclamation machinery, agricultural machinery and equipment, building products, fertilizers, and agricultural chemicals. The firm seeks to invest in North America with a focus on the United States; South America; Asia with a focus on India and China; Europe with a focus on Western Europe and Benelux regions; and other emerging markets.  It also seeks to make co-investments.   Founded in 2000, SAM Private Equity is based in Zurich, Switzerland.

SAM Private Equity

Eastbourne Capital Management privately owned investment manager.

Eastbourne Capital Management

Advanced BioNutrition

Advanced BioNutrition develops functional ingredients to improve animal health and functional nutrition in the aquaculture area.  The company focused on offering environmentally sustainable and science-based bioactive stabilization and delivery solutions to a variety of industries, spanning from human nutrition and health and human biologics to agriculture, food ingredients, and food safety. It continues to explore new verticals based on technologies available with over 40 patents. Since the company’s inception in 2001, ABN’s visionary scientists and engineers have helped the company grow into a diversified provider of solutions that better stabilize, protect, and deliver bio-actives to their targeted sites.

Advanced BioNutrition Corp (ABN) is a technology provider established in 2001 that develops environmentally sustainable and science-based stabilization and delivery solutions across multiple industries. The company specializes in bioactive and microbial stabilization technologies for human nutrition and health, human biologics, agriculture, food ingredients, and food safety applications. ABN has built its intellectual property portfolio with over 40 patents related to its stabilization and delivery technologies. The company's core focus initially began in sustainable aquaculture nutrition and fish health before expanding into broader applications. ABN leverages its scientific expertise through an experienced team of researchers and engineers who work on innovating and commercializing delivery solutions.

Advanced Bionutritionals Reviews – Is It Worth It?

Advanced BioNutrition Corp（ABN）

Advanced Bionutritionals Reviews

Advanced Bionutritionals Review: Is This Company Worth Trusting?

Advanced Bionutritionals Reviews - Quality Health Supplements Or Cheap Wellness Products?

Advanced Bionutritionals Advanced Vision Formula Reviews - Real Ingredients

Advanced BioNutrition Corp.

Unlocking nature's benefits for elevated wellness

Functional Nutrition Ingredients

Advanced BioNutrition Corp (ABN) is a technology provider established in 2001 that develops environmentally sustainable and science-based stabilization and delivery solutions across multiple industries. The company specializes in bioactive and microbial stabilization technologies for human nutrition and health, human biologics, agriculture, food ingredients, and food safety applications. ABN has built its intellectual property portfolio with over 40 patents related to its stabilization and delivery technologies. The company's core focus initially began in sustainable aquaculture nutrition and fish health before expanding into broader applications. ABN leverages its scientific expertise through an experienced team of researchers and engineers who work on innovating and commercializing delivery solutions.
Key customers and partnerships
ABN continues to work with various suppliers and manufacturers across industries like human nutrition, agriculture and food safety. The company maintains a focus on environmental sustainability while serving these different market segments through its proprietary technologies and solutions.

Certified Nutraceuticals specializes in developing bio-active ingredients for foods, beverages, and supplements. The company holds 16 US patents for ingredients and extraction processes related to pomegranate, olive leaf, grapevine extracts, and jellyfish collagen. The company pioneered the introduction of Collagen Types I, II, and III as nutritional supplements and developed three collagen ingredients: KollaGen II-xs, kollaGen I.V.X.HEM, and TendoGuard Joint and Tendon Support, which contains collagen types I, II, V, and X. In 2001, the company patented a unique method to extract collagen from chicken sternums, used in products for joint pain relief and mobility restoration. Their ingredients support healthy aging, joint health, brain health, and cognitive function. The company's manufacturing processes comply with Fair Trade criteria, eco and dietary regulations, FDA guidelines, and Kosher and Halal requirements. All products undergo analysis in accordance with the Federal Drug Administration and Cosmetics Act and the Fair Packaging and Labelling Act. The company provides comprehensive services from initial product development to manufacturing, filling, and product launch, including logistics and disposition.
Key customers and partnerships
The company maintains an international network of distributors, wholesalers, and manufacturing partners. Among these partnerships is a collaboration with Nutraceuticals Agriceuticals Technology Company (NATCO), a leading supplier of organic monk fruit and persimmons, which operates farms and factories in Guilin, China.

Certified Nutraceuticals

Nupromic is a biotechnology company that specializes in developing functional ingredients and next-generation nutraceutical products for the food industry. The company operates Mexico's first Beta Glucan production facility and manufactures differentiated ingredients used in fortified food production.

Nupromic

Beneo is a manufacturer of functional ingredients derived from natural sources including chicory root, sugar beet, rice, and wheat for food, feed, and pharmaceutical products. The company specializes in producing functional carbohydrates, fibers, and proteins that improve nutritional and technical properties of various products. Its portfolio includes Isomalt and Palatinose (sugar beet-derived carbohydrates), Orafti Inulin and Oligofructose (chicory root fibers), and wheat and rice proteins. These ingredients are used across multiple applications including dairy, confectionery, bakery, cereals, baby food, and beverages to enhance taste, texture, and nutritional benefits. In May 2022, Beneo acquired Meatless B.V., a Dutch supplier of textured plant-based ingredients, expanding its capabilities in meat and fish alternatives. The company has six production facilities located in Belgium, Chile, Germany, Italy, and the Netherlands. Beneo invested EUR 7.7 million in March 2022 to quadruple storage capacity at its Offstein, Germany facility with a new automated warehouse capable of storing over 8,500 pallets. In 2022, the company also announced a EUR 50 million investment in a new fava bean processing plant in Offstein to produce protein concentrates, starch-rich flour, and hulls, scheduled for completion in late 2024.

Beneo

AlgaeCytes is a biotechnology company specializing in the cultivation of algae to produce health and wellness ingredients. The company utilizes an advanced photobioreactor system for algae cultivation, featuring enclosed glass tubing and LED lighting to stimulate photosynthesis. AlgaeCytes' patented process optimizes the photosynthetic process, allowing microalgae to flourish and produce valuable compounds. The system regulates light, nutrient supply, and temperature, enabling efficient and consistent production year-round, regardless of external weather conditions.
The company's primary focus is on producing omega-3 oils from microalgae as an alternative to fish-derived sources. This approach offers several advantages, including suitability for vegetarian diets, reduced pressure on fish stocks, and the ability to avoid potential contamination with trace heavy metals sometimes found in fish oil supplements. AlgaeCytes' method allows for the production of high-quality omega-3 oils with variable EPA:DHA ratios, catering to different formulation requirements.
In February 2018, AlgaeCytes joined the ProFlow consortium, which secured an Innovate UK grant of nearly GBP 630,000 for a two-year development program. The consortium aims to scale up a novel acoustic cell harvesting technology developed by LabXero, which could significantly reduce the costs associated with separating algal biomass from its culture medium. This technology uses resonant sound waves to create an acoustic barrier, separating water from microalgae without the need for energy-intensive centrifugation techniques. The development of this technology could potentially lower downstream processing costs, which constitute a substantial portion of total processing expenses in algae-based omega-3 production.

AlgaeCytes

Seed Health is a microbiome science company founded in 2015 by Ara Katz and Raja Dhir. The company focuses on developing probiotics and living medicines to impact both human and planetary health. Seed Health's flagship product is DS-01, a daily synbiotic (probiotic + prebiotic) supplement formulated with 24 clinically studied bacterial strains targeting digestive, cardiovascular, dermatological, and immune health. In May 2024, the company launched vs.-01, a vaginal synbiotic clinically validated to establish an optimal vaginal microbiome dominated by Lactobacillus crispatus.
Seed Health utilizes a full-stack platform that encompasses discovery, product development, and clinical research. The company employs bioinformatics and computational analyses to interrogate the role of the microbiome in overall health and design targeted probiotics. In April 2024, Seed Health introduced CODA, a computational biology platform powered by the Human Phenotype Project, which integrates over three million phenotypic data points from more than 13,000 individuals. This platform aims to develop next-generation precision probiotics and microbiome-directed interventions for areas including metabolic health, brain health, menopause, and longevity.
The company's research extends beyond human health to environmental applications through its SeedLabs division. This includes developing probiotics for honeybees to enhance their resilience against climate change-related stressors, as well as exploring microbial solutions for plastic degradation and soil health. Seed Health collaborates with leading scientists and research institutions to advance its work across various health domains, including vaginal health, skin health, oral hygiene, pediatrics, mental health, and nutrition.
Key customers and partnerships
The company has established partnerships with several academic and research institutions to further its scientific endeavors. In 2023, Seed Health announced a collaboration with the Swiss Institute of Allergy and Asthma Research (SIAF) to develop non-toxic, microbiome-safe home and personal care products. The company also partnered with Axial Therapeutics in 2022 to launch a Gut-Brain Development Program, focusing on translating research from Caltech into probiotic innovations for neuropsychiatric health.

Seed Health

Live beneficial microorganisms and non-digestible fibers to promote a balanced gut microbiome and improve digestive health

Plant-based extracts, fibers, and herbal ingredients with health-promoting properties like anti-inflammatory, adaptogenic, and antioxidant effects

Essential fatty acids and structured lipids such as omega-3 and amino acids that support heart health, cognitive function, and energy metabolism

Small protein fragments with targeted biological activities, such as boosting immunity, improving cardiovascular health, and reducing inflammation

Essential micronutrients and compounds that support improved immune system function, bone health, hair, and skin, among others

Advanced BioNutrition

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless